| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/03/2012 | US8088388 Complexing; water in oil emulsion; immunostimulant |
| 01/03/2012 | US8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies |
| 01/03/2012 | US8088371 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
| 01/03/2012 | CA2640402C Alpha-2-delta ligands for non-restorative sleep |
| 01/03/2012 | CA2628794C Treatment of length dependent neuropathy |
| 01/03/2012 | CA2528160C Use of 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl) piperazine for neuronal regeneration and functional recovery |
| 01/03/2012 | CA2514407C Thienopyrimidine compounds and use thereof |
| 01/03/2012 | CA2499622C Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 01/03/2012 | CA2495060C Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications |
| 01/03/2012 | CA2495058C C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants |
| 01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 01/03/2012 | CA2481321C [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
| 01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/03/2012 | CA2468910C Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 01/03/2012 | CA2463134C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/03/2012 | CA2457719C Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 01/03/2012 | CA2456717C Phenyl derivatives as factor xa inhibitors |
| 01/03/2012 | CA2455972C N6-benzyl and phenyl substituted adenines and their use as cosmetics, pharmaceutical preparations and plant growth regulators |
| 01/03/2012 | CA2445835C 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 01/03/2012 | CA2425558C Lactam compound |
| 01/03/2012 | CA2419954C Use of il-6r/il-6 chimera in huntington's disease |
| 12/29/2011 | WO2011163652A2 Treatment of sanfilippo syndrome type b |
| 12/29/2011 | WO2011163651A2 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF β-GALACTOCEREBROSIDASE |
| 12/29/2011 | WO2011163650A2 Methods and compositions for cns delivery of arylsulfatase a |
| 12/29/2011 | WO2011163649A2 Methods and compositions for cns delivery of iduronate-2-sulfatase |
| 12/29/2011 | WO2011163647A2 Methods and compositions for cns delivery of heparan n-sulfatase |
| 12/29/2011 | WO2011163636A2 Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms |
| 12/29/2011 | WO2011163560A1 Methods of treatment using sterculic acid |
| 12/29/2011 | WO2011163394A2 Compstatin analogs for treatment of neuropathic pain |
| 12/29/2011 | WO2011163355A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 12/29/2011 | WO2011162655A1 Compound and method for treatment of alzheimer's disease and familial dementia |
| 12/29/2011 | WO2011162480A2 Composition for treating prion diseases comprising hif-1α agonist |
| 12/29/2011 | WO2011162267A1 Novel thiophenecarboxamide derivatives and use thereof as medicine |
| 12/29/2011 | WO2011161537A2 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/29/2011 | WO2011161484A1 Use of an estrogen derivative for the manufacture of pharmaceutical compositions useful for the treatment and/or prevention of psychiatric diseases and for the treatment and prevention of said diseases |
| 12/29/2011 | WO2011161439A1 Pharmaceutical composition comprising midazolam |
| 12/29/2011 | WO2011161282A1 Use of rapamycin for the treatment of the cognitive deficits associated with down's syndrome |
| 12/29/2011 | WO2011161249A1 Use of 1h-quinazoline-2,4-diones |
| 12/29/2011 | WO2011161191A1 Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents |
| 12/29/2011 | WO2011161127A1 Protease variants of human neprilysin |
| 12/29/2011 | WO2011161096A1 Iodinated activated charcoal for treating symptoms of depression |
| 12/29/2011 | WO2011161009A1 Anellated pyridine compounds as dual modulators of the 5-ht2a and d3 receptors |
| 12/29/2011 | WO2011161008A1 Quinolizidine and indolizidine derivatives |
| 12/29/2011 | WO2011161006A1 Amido-tropane derivatives |
| 12/29/2011 | WO2011160845A2 Oxidized phospholipids and lipoproteins, and antibodies thereto, as biomarkers of inflammatory conditions and methods of treatment |
| 12/29/2011 | WO2011160732A1 Protease variants of human neprilysin |
| 12/29/2011 | WO2011160632A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 12/29/2011 | WO2011160548A1 2-aryl imidazo[1,2-a]pyridine-3-acetamide derivatives, preparation methods and use thereof |
| 12/29/2011 | WO2011160268A1 Phosphoric acid ester compound of hydroxy acid substituted phenyl ester, synthesis method and medical use thereof |
| 12/29/2011 | WO2011160267A1 Hydroxy acid compound of substituted phenyl ester, preparation method and medical use thereof |
| 12/29/2011 | WO2011160189A1 METHOD OF SCREENING FOR INHIBITORS OF sPLA2-IIA |
| 12/29/2011 | WO2011125006A3 Sultam compounds |
| 12/29/2011 | WO2011121452A3 Crystal forms of o-desmethylvenlafaxine fumarate |
| 12/29/2011 | WO2011109767A3 Gelatinase inhibitors and prodrugs |
| 12/29/2011 | WO2011100550A3 Compositions and methods for treating depression |
| 12/29/2011 | WO2011089168A3 Special composition for the use thereof as a drug |
| 12/29/2011 | WO2011041634A8 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| 12/29/2011 | WO2010132882A8 Sublingual dexmedetomidine compositions and methods of use thereof |
| 12/29/2011 | WO2010129138A3 Phosphorylated and phosphonated pyrone analogs for therapeutic treatment |
| 12/29/2011 | US20110319494 Substituted Aryl-Indole Compounds and Their Kynurenine/Kynuramine-Like Metabolites As Therapeutic Agents |
| 12/29/2011 | US20110319490 Methods and compositions for the treatment of irritable bowel syndrome |
| 12/29/2011 | US20110319484 Neuroprotective compounds |
| 12/29/2011 | US20110319482 Novel treatments |
| 12/29/2011 | US20110319476 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf |
| 12/29/2011 | US20110319475 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 12/29/2011 | US20110319465 Estrogen receptor modulators and uses thereof |
| 12/29/2011 | US20110319459 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System |
| 12/29/2011 | US20110319458 Compound with agitation effect on peroxisome proliferator-activated receptor. process for its preparation and use thereof |
| 12/29/2011 | US20110319456 Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same |
| 12/29/2011 | US20110319449 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| 12/29/2011 | US20110319440 Process for Preparing Spirocyclic Cyclohexane Compounds, Compositions Containing Such Compounds and Method of Using Such Compounds |
| 12/29/2011 | US20110319439 Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
| 12/29/2011 | US20110319436 Methods and Compositions for Modulating IRE1, SRC, and ABL Activity |
| 12/29/2011 | US20110319434 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof |
| 12/29/2011 | US20110319433 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treatment of inflammation |
| 12/29/2011 | US20110319431 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 12/29/2011 | US20110319429 Substituted 1,1,3,1-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 12/29/2011 | US20110319426 Substituted Isoindoles |
| 12/29/2011 | US20110319425 Heterotricyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 12/29/2011 | US20110319423 Novel dopamine d3 receptor ligands and preparation and medical uses of the same |
| 12/29/2011 | US20110319421 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 12/29/2011 | US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor |
| 12/29/2011 | US20110319418 Prokineticin 1 receptor antagonists for the treatment of pain |
| 12/29/2011 | US20110319417 Methods and compositions for treating anxiety |
| 12/29/2011 | US20110319416 Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions |
| 12/29/2011 | US20110319414 Novel triazine derivative and pharmaceutical composition comprising the same |
| 12/29/2011 | US20110319411 Isoindolinone and related analogs as sirtuin modulators |
| 12/29/2011 | US20110319410 Pyrazine derivatives and use as pi3k inhibitors |
| 12/29/2011 | US20110319409 7-aza-quinazoline pde10 inhibitors |
| 12/29/2011 | US20110319408 Methods of Treating Fibrosis, Cancer and Vascular Injuries |
| 12/29/2011 | US20110319407 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof |
| 12/29/2011 | US20110319406 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 12/29/2011 | US20110319397 Novel n-oxides of furanyl-oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 12/29/2011 | US20110319395 Pharmaceutical Formulation of Olanzapine |
| 12/29/2011 | US20110319394 Fused heterocyclic compounds |
| 12/29/2011 | US20110319391 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |
| 12/29/2011 | US20110319389 Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
| 12/29/2011 | US20110319388 Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| 12/29/2011 | US20110319387 Indole derivatives for treating neurodegenerative diseases |
| 12/29/2011 | US20110319386 Neurogenesis by muscarinic receptor modulation |